Price to Sales ratio Analysis of Immuneering Corp - Deep Dive


Latest FY PS
Period Ending - Dec-23

91807341


Very Poor PS
Period Ending - Dec-22
122.38

Very Poor PS
Growth
75017953 %
Trailing Twelve Months PS
Period Ending - Dec-23

0


Very Poor PS
PS Analysis of Immuneering Corp
PS Ratio of IMRX rose handsomely by 75017953 % this year.
PS Ratio of IMRX trending up for at least three Years.
PS Ratio with value of 5.46 was lowest in Year Dec-20 in last Five Years.
Latest PS Ratio with value of 91807341 is Greater than Average PS of 18361497 in last five years.
Other PS Related Info of IMRX that may interest you.
Immuneering Corp Overview
CodePricePrevious PricePrice ChangeSector
IMRX1.471.54 4.55 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
No Significant Value
FY - Historical Price to Sales of Immuneering Corp
PeriodDec-23Dec-22Dec-21Dec-20Dec-19
PS91807341122.389.625.466.57
Change75017953 %1172.08 %76.34 %-16.95 %
FY Chart of Price to Sales of Immuneering Corp


Note : All Data Generated at the End of Trading Hours (EOD Data)